CHINA CBA champion Ji Zhe dies of lung cancer at 33

CHINA

CBA champion Ji Zhe dies of lung cancer at 33

Xinhua

11:08, December 05, 2019

VCG111147818599.jpg

File photo: VCG

BEIJING, Dec. 5 (Xinhua) -- Former Beijing Ducks' player Ji Zhe, three-time winner of the Chinese Basketball Association (CBA) league, died of lung cancer early on Thursday.

"2:14 a.m. on December 5, 2019, after fighting against lung cancer for over a year, Ji Zhe left us," the Beijing Ducks said in a statement on social platform.

Ji was diagnosed with the disease last August, before going to the United States for treatment.

"Ji has gone. He will love basketball as always, like he's never gone. His No. 51 jersey will stay here forever," read the statement.

Ji joined the Beijing Ducks in 2007. The 2.02m-tall power forward was regarded as a good rim protector, contributing to the team on both ends with his jumpers, three-pointers and rebounds, also impressing fans with his passion on the court.

He claimed the CBA championship title in 2012, 2014 and 2015 along with Stephon Marbury, current head coach of the Beijing Royal Fighters.

"This moment I feel saddened for your family members who love you. My bro, my teammate, my companion, my captain, I hope everything is smooth in the other world. I pray that your family members can bear the pain of loss, and hope they can stand in braveness. They can feel the energy by people who love you everywhere in the world. R.I.P," Marbury wrote on social platform.

"Hopefully basketball will accompany you in the heaven! R.I.P," wrote Yi Jianlian, the CBA's all-time leading scorer from the Guangdong Southeast Tigers.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue